|
|
 |
|
|
|
 |
|
1 - 10 of 257 Shown
|
Articles per page
|
25 |
50
|
|
All
Date |
| Hide

 |
| 2000 Policy Directives from the Rehabilitation Services Administration (RSA).
(Sep 15, 2003)
|
| Notice of Vendor on List of Parties Excluded from Federal Procurement and Non-procurement Programs. |
 |
| 2000 Policy Directives from the Rehabilitation Services Administration (RSA).
(Sep 15, 2003)
|
| Notice of Vendor on List of Parties Excluded from Federal Procurement and Non-procurement Programs. |
 |
| 2004 Parts B and C Grant Award Application Packages
(Dec 04, 2003)
|
| 2004 Parts B and C Grant Award Application Packages for IDEA. |
 |
| 2005 Parts B and C Grant Award Application Packages
(Mar 02, 2005)
|
| 2005 Parts B and C Grant Award Application Packages for IDEA. |
 |
| Annual State Application Under Part B Of the Individuals With Disabiliteis Education Act for Federal Fiscal Year 2005 (CFDA Nos. 84.027 and 84.173) (MS Word)
(Mar 02, 2005)
|
| Cover Page and Application Parts I and II to apply for Funds Under Part B of IDEA FFY 2005. |
 |
| Annual State Application Under Part B of the Individuals with Disabilities Education Act (MS Word)
(Mar 02, 2005)
|
| Submission Statement for Part B in IDEA |
 |
| Annual State Application Under Part C of the Individuals with Disabilities Education Act (MS Word)
(Mar 02, 2005)
|
| Submission Statement for Part C in IDEA |
 |
| August 9, 2005 to Virgin Islands Educational Consultant Eleanor Hirsh (PDF)
(Nov 29, 2005)
|
| Policy correspondence interpreting IDEA or the regulations that implement IDEA |
 |
| Certifications Regarding Lobbying; debarment, Suspension And Other responsibility Matters; Drug-Free Workplace Requirements (MS Word)
(Mar 02, 2005)
|
| Outlines the guidelines for lobbying and requirements grantees to maintain a drug-free workplace. |
 |
| Certifications Regarding Lobbying; debarment, Suspension And Other responsibility Matters; Drug-Free Workplace Requirements (MS Word)
(Mar 02, 2005)
|
| Outlines the guidelines for lobbying and requirements grantees to maintain a drug-free workplace. |
 |
 |
|
|
|
 |
|
|
|